Skip to main content
OpenTrials

Clinical trial condition

Dyslipidemias

Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.

948 public trials 78 recruiting studies
Refine in advanced search Browse all conditions

Dyslipidemias trial results

Active, Not Recruiting

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

NCT05030428

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +9 more
Locations
  • UAB St Vincents Birmingham, Alabama, United States
  • Eastern Shore Research Institute Fairhope, Alabama, United States
  • G and L Research LLC Foley, Alabama, United States
  • Alaska Heart and Vascular Anchorage, Alaska, United States
View all 989 locations
View Trial Details
Active, Not Recruiting

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

NCT05739383

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Brain Diseases, +24 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • UAB St Vincents Birmingham, Alabama, United States
  • Eastern Shore Research Institute Fairhope, Alabama, United States
  • G and L Research LLC Foley, Alabama, United States
View all 986 locations
View Trial Details
Active, Not Recruiting

A Study of DII235 in Adults With Elevated Lipoprotein(a)

NCT07235046

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +8 more
Locations
  • Parkway Medical Center Birmingham, Alabama, United States
  • Heart Center Research Llc Huntsville, Alabama, United States
  • Cardiology and Medicine Clinic PA Little Rock, Arkansas, United States
  • National Heart Institute Beverly Hills, California, United States
View all 63 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With Dyslipidaemia

NCT07218900

Conditions
Dyslipidaemia, Dyslipidemias, Lipid Metabolism Disorders, +2 more
Locations
  • Research Site Aramil, Russia
  • Research Site Ivanovo, Russia
  • Research Site Moscow, Russia
  • Research Site Moscow, Russia
View Trial Details
Active, Not Recruiting

A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

NCT04951219

Conditions
Digestive System Diseases, Dyslipidemias, Endocrine System Diseases, +14 more
Locations
  • Central Research Associates Birmingham, Alabama, United States
  • Arizona Liver Health - Chandler Chandler, Arizona, United States
  • East Valley Family Physicians Chandler, Arizona, United States
  • The Institute For Liver Health - Glendale Glendale, Arizona, United States
View all 76 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia

NCT06238466

Conditions
Cardiovascular, Dyslipidemias, Lipid Metabolism Disorders, +2 more
Locations
  • Research Site Glendale, California, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Winter Park, Florida, United States
  • Research Site Baltimore, Maryland, United States
View Trial Details

Related conditions